Risk factors for rejection and infection in pediatric liver transplantation

American Journal of Transplantation

Volumn 8, Issue 2, 2008, Pages 396-403

  Shepherd, R W ^a   Turmelle, Y ^a   Nadler, M ^a   Lowell, J A ^a   Narkewicz, M R ^b   McDiarmid, S V ^c   Anand, R ^d   Song, C ^d  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMMES CORPORATION   (United States)

Author keywords

Infection; Liver transplantation; Pediatric; Rejection; Risk factors

Indexed keywords

BILIRUBIN; CYCLOSPORIN; TACROLIMUS;

ARTICLE; BACTERIAL INFECTION; CAUSE OF DEATH; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GRAFT FAILURE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; MYCOSIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS INFECTION;

ADOLESCENT; CAUSE OF DEATH; CHILD; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RECURRENCE; REOPERATION; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 38149081333     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02068.x     Document Type: Article

References (28)

1. Colombani PM, Dunn SP, Harmon WE, Magee JC, McDiarmid SV, Spray TL. Pediatric transplantation. Am J Transplant 2003 3 (Suppl 4 53 63.
2. Martin SR, Atkison P, Anand R, Lindblad AS, SPLIT Research Group. Studies of Pediatric Liver Transplantation 2002: Patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004 8 : 273 283.
3. Utterson EC, Shepherd RW, Sokol RJ et al. Biliary atresia: Clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005 147 : 180 185.
4. Jain A, Mazariegos G, Kashyap R et al. Pediatric liver transplantation: A single center experience spanning 20 years. Transplantation 2002 73 : 941 947.
5. Hollenbeak CS, Alfrey EJ, Sheridan K, Burger TL, Dillon PW. Surgical site infections following pediatric liver transplantation: Risks and costs. Transpl Infect Dis 2003 5 : 72 78.
6. Quiros-Tejeira RE, Ament ME, McDiarmid SV et al. Late-onset bacteremia in uncomplicated pediatric liver-transplant recipients after a febrile episode. Transpl Int 2002 15 (9-10 502 507 Epub 2002 Sep 19 M, Holmberg C, Lautenschlager I, Hockerstedt K, Jalanko H. Infections in pediatric kidney and liver transplant patients after perioperative hospitalization. Transplantation 2000 69 : 1617 1623.
7. George DL, Arnow PM, Fox A et al. Patterns of infection after pediatric liver transplantation. Am J Dis Child 1992 146 : 924 929.
8. Sokal EM, Antunes H, Beguin C et al. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation 1997 64 : 1438 1442.
9. Mellon A, Shepherd RW, Faoagali JL et al. Cytomegalovirus infection after liver transplantation in children. J Gastroenterol Hepatol 1993 8 : 540 544.
10. McDiarmid SV, Anand R, SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): A summary of the 2003 Annual Report. Clin Transpl 2003 119 130.
11. McDiarmid SV, Anand R, Lindblad AS, SPLIT Research Group. Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 2004 8 : 284 294.
12. McDiarmid SV, Anand R, Lindblad AS, Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002 74 : 173 181.
13. Al-Hussaini A, Tredger JM, Dhawan A. Immunosuppression in pediatric liver and intestinal transplantation: A closer look at the arsenal. J Pediatr Gastroenterol Nutr 2005 41 : 152 165.
14. Schuller S, Wiederkehr JC, Coelho-Lemos IM, Avilla SG, Schultz C. Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation. Transplant Proc 2005 37 : 1151 1152.
15. Heffron TG, Pillen T, Smallwood GA, Welch D, Oakley B, Romero R. Pediatric liver transplantation with daclizumab induction. Transplantation 2003 75 : 2040 2043.
16. Ganschow R, Grabhorn E, Schulz A, Von Hugo A, Rogiers X, Burdelski M. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients. Pediatr Transplant 2005 9 : 741 745.
17. Tredger JM, Brown NW, Dhawan A. Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management. Pediatr Transplant 2006 10 : 879 892.
18. Champion L, Stern M, Israel-Biet D et al. Brief communication: Sirolimus-associated pneumonitis: 24 cases in transplant recipients. Ann Intern Med 2006 144 : 505 509.
19. Bucuvalas JC, Campbell KM, Cole CR, Guthery SL. Outcomes after liver transplantation: keep the end in mind. J Pediatr Gastroenterol Nutr 2006 43 (Suppl 1 S41 S48.
20. Jain A, Mazariegos G, Pokharna R et al. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: A long-term analysis. Transplantation 2003 75 : 1020 1025.
21. Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: Long term results and future prospects. Transpl Immunol 2007 17 : 114 119 Epub 2006, Oct 17 T, Li Y, Takemura M et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007 17 : 94 97 Epub 2006, Nov 10).
22. Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001 1 : 233 239.
23. Miller J, Mathew JM, Esquenazi V. Toward tolerance to human organ transplants: A few additional corollaries and questions. Transplantation 2004 77 : 940 942.
24. Daebritz SH, Schmoeckel M, Mair H, Kozlik-Feldmann R, Wittmann G, Kowalski C, Kaczmarek I, Reichart B. Blood type incompatible cardiac transplantation in young infants. Eur J Cardiothorac Surg 2007 31 : 339 343. discussion 343. (Epub 2007, Jan 17.)
25. Wiesner RH, Demetris AJ, Belle SH et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998 28 : 638 645.
26. Lee TC, Goss JA, Rooney CM et al. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant 2006 20 : 689 694.
27. Chin SE, Shepherd RW, Cleghorn GJ et al. Pre-operative nutritional support in children with end-stage liver disease accepted for liver transplantation: An approach to management. J Gastroenterol Hepatol 1990 5 : 566 572.
28. Chin SE, Shepherd RW, Thomas BJ et al. Nutritional support in children with end-stage liver disease: A randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992 56 : 158 163.